Ian F. Smith

Vertex Pharmaceuticals

EVP & Chief Operating Officer

Overview

Ian F. Smith received an average compensation of $5,536,759 at Vertex Pharmaceuticals from 2006 to 2017.

Annual data

2017

In 2017, Ian F. Smith earned a total compensation of $5,936,236 as EVP & Chief Operating Officer at Vertex Pharmaceuticals.

Ranking1,372 out of 13,165
Percentile89.6%

Ian F. Smith's 2017 compensation ranked 1,372nd out of 13,165 executive pay records tracked by us this year.

Ian F. Smith earned more than 89.6% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking66 out of 1,094
Percentile94.0%

In the industry of pharmaceutical preparations, Ian F. Smith's 2017 pay ranked 66th, among 1,094 executive pay records.

Ian F. Smith earned more than 94.0% of executives in this industry.

Non-Equity Incentive Plan$1,339,770
Option Awards$1,110,263
Salary$848,077
Stock Awards$2,625,016
Other$13,110
Total$5,936,236

Smith received $2,625,016 in stock awards, which accounts for 44.22% of total compensation.

Smith also received $1,339,770 in non-equity incentive plan, $1,110,263 in option awards, $848,077 in salary and $13,110 in other compensation.

2016

In 2016, Ian F. Smith earned a total compensation of $5,780,677 as EVP & Chief Operating Officer and CFO at Vertex Pharmaceuticals.

Ranking1,274 out of 13,853
Percentile90.8%

Ian F. Smith's 2016 compensation ranked 1,274th out of 13,853 executive pay records tracked by us this year.

Ian F. Smith earned more than 90.8% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking58 out of 1,120
Percentile94.8%

In the industry of pharmaceutical preparations, Ian F. Smith's 2016 pay ranked 58th, among 1,120 executive pay records.

Ian F. Smith earned more than 94.8% of executives in this industry.

Non-Equity Incentive Plan$562,500
Option Awards$1,305,144
Salary$750,000
Stock Awards$3,150,148
Other$12,885
Total$5,780,677

Smith received $3,150,148 in stock awards, which accounts for 54.49% of total compensation.

Smith also received $562,500 in non-equity incentive plan, $1,305,144 in option awards, $750,000 in salary and $12,885 in other compensation.

2015

In 2015, Ian F. Smith earned a total compensation of $9,005,983 as EVP & Chief Operating Officer and CFO at Vertex Pharmaceuticals.

Ranking631 out of 13,574
Percentile95.4%

Ian F. Smith's 2015 compensation ranked 631st out of 13,574 executive pay records tracked by us this year.

Ian F. Smith earned more than 95.4% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking47 out of 1,144
Percentile95.9%

In the industry of pharmaceutical preparations, Ian F. Smith's 2015 pay ranked 47th, among 1,144 executive pay records.

Ian F. Smith earned more than 95.9% of executives in this industry.

Non-Equity Incentive Plan$832,500
Option Awards$5,199,586
Salary$701,796
Stock Awards$2,258,991
Other$13,110
Total$9,005,983

Smith received $5,199,586 in option awards, which accounts for 57.73% of total compensation.

Smith also received $832,500 in non-equity incentive plan, $701,796 in salary, $2,258,991 in stock awards and $13,110 in other compensation.

2014

In 2014, Ian F. Smith earned a total compensation of $15,303,863 as EVP & Chief Operating Officer and CFO at Vertex Pharmaceuticals.

Ranking218 out of 12,876
Percentile98.3%

Ian F. Smith's 2014 compensation ranked 218th out of 12,876 executive pay records tracked by us this year.

Ian F. Smith earned more than 98.3% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking23 out of 1,003
Percentile97.7%

In the industry of pharmaceutical preparations, Ian F. Smith's 2014 pay ranked 23rd, among 1,003 executive pay records.

Ian F. Smith earned more than 97.7% of executives in this industry.

Non-Equity Incentive Plan$731,250
Option Awards$4,044,646
Salary$650,000
Stock Awards$9,865,110
Other$12,857
Total$15,303,863

Smith received $9,865,110 in stock awards, which accounts for 64.46% of total compensation.

Smith also received $731,250 in non-equity incentive plan, $4,044,646 in option awards, $650,000 in salary and $12,857 in other compensation.

2013

In 2013, Ian F. Smith earned a total compensation of $4,184,762 as EVP & Chief Financial Officer at Vertex Pharmaceuticals.

Ranking1,618 out of 11,965
Percentile86.5%

Ian F. Smith's 2013 compensation ranked 1,618th out of 11,965 executive pay records tracked by us this year.

Ian F. Smith earned more than 86.5% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking83 out of 844
Percentile90.2%

In the industry of pharmaceutical preparations, Ian F. Smith's 2013 pay ranked 83rd, among 844 executive pay records.

Ian F. Smith earned more than 90.2% of executives in this industry.

Non-Equity Incentive Plan$682,500
Option Awards$2,361,640
Salary$582,959
Stock Awards$544,988
Other$12,675
Total$4,184,762

Smith received $2,361,640 in option awards, which accounts for 56.43% of total compensation.

Smith also received $682,500 in non-equity incentive plan, $582,959 in salary, $544,988 in stock awards and $12,675 in other compensation.

2012

In 2012, Ian F. Smith earned a total compensation of $3,109,193 as EVP & Chief Financial Officer at Vertex Pharmaceuticals.

Ranking2,193 out of 10,949
Percentile80.0%

Ian F. Smith's 2012 compensation ranked 2,193rd out of 10,949 executive pay records tracked by us this year.

Ian F. Smith earned more than 80.0% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking82 out of 644
Percentile87.3%

In the industry of pharmaceutical preparations, Ian F. Smith's 2012 pay ranked 82nd, among 644 executive pay records.

Ian F. Smith earned more than 87.3% of executives in this industry.

Non-Equity Incentive Plan$376,577
Option Awards$1,723,546
Salary$539,241
Stock Awards$457,379
Other$12,450
Total$3,109,193

Smith received $1,723,546 in option awards, which accounts for 55.43% of total compensation.

Smith also received $376,577 in non-equity incentive plan, $539,241 in salary, $457,379 in stock awards and $12,450 in other compensation.

2011

In 2011, Ian F. Smith earned a total compensation of $3,344,580 as EVP & Chief Financial Officer at Vertex Pharmaceuticals.

Ranking1,791 out of 10,035
Percentile82.2%

Ian F. Smith's 2011 compensation ranked 1,791st out of 10,035 executive pay records tracked by us this year.

Ian F. Smith earned more than 82.2% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking67 out of 515
Percentile87.0%

In the industry of pharmaceutical preparations, Ian F. Smith's 2011 pay ranked 67th, among 515 executive pay records.

Ian F. Smith earned more than 87.0% of executives in this industry.

Non-Equity Incentive Plan$425,493
Option Awards$1,914,319
Salary$523,535
Stock Awards$468,738
Other$12,495
Total$3,344,580

Smith received $1,914,319 in option awards, which accounts for 57.24% of total compensation.

Smith also received $425,493 in non-equity incentive plan, $523,535 in salary, $468,738 in stock awards and $12,495 in other compensation.

2010

In 2010, Ian F. Smith earned a total compensation of $3,122,481 as EVP & Chief Financial Officer at Vertex Pharmaceuticals.

Ranking1,805 out of 9,477
Percentile81.0%

Ian F. Smith's 2010 compensation ranked 1,805th out of 9,477 executive pay records tracked by us this year.

Ian F. Smith earned more than 81.0% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking54 out of 442
Percentile87.8%

In the industry of pharmaceutical preparations, Ian F. Smith's 2010 pay ranked 54th, among 442 executive pay records.

Ian F. Smith earned more than 87.8% of executives in this industry.

Non-Equity Incentive Plan$459,000
Option Awards$1,688,073
Salary$491,220
Stock Awards$471,759
Other$12,429
Total$3,122,481

Smith received $1,688,073 in option awards, which accounts for 54.06% of total compensation.

Smith also received $459,000 in non-equity incentive plan, $491,220 in salary, $471,759 in stock awards and $12,429 in other compensation.

2009

In 2009, Ian F. Smith earned a total compensation of $9,104,036 as EVP & Chief Financial Officer at Vertex Pharmaceuticals.

Ranking251 out of 8,703
Percentile97.1%

Ian F. Smith's 2009 compensation ranked 251st out of 8,703 executive pay records tracked by us this year.

Ian F. Smith earned more than 97.1% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking20 out of 418
Percentile95.2%

In the industry of pharmaceutical preparations, Ian F. Smith's 2009 pay ranked 20th, among 418 executive pay records.

Ian F. Smith earned more than 95.2% of executives in this industry.

Non-Equity Incentive Plan$403,245
Option Awards$7,803,839
Salary$479,250
Stock Awards$405,297
Other$12,405
Total$9,104,036

Smith received $7,803,839 in option awards, which accounts for 85.72% of total compensation.

Smith also received $403,245 in non-equity incentive plan, $479,250 in salary, $405,297 in stock awards and $12,405 in other compensation.

2008

In 2008, Ian F. Smith earned a total compensation of $2,262,326 as Executive Vice President and Chief Financial Officer at Vertex Pharmaceuticals.

Ranking1,917 out of 7,730
Percentile75.2%

Ian F. Smith's 2008 compensation ranked 1,917th out of 7,730 executive pay records tracked by us this year.

Ian F. Smith earned more than 75.2% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking63 out of 378
Percentile83.3%

In the industry of pharmaceutical preparations, Ian F. Smith's 2008 pay ranked 63rd, among 378 executive pay records.

Ian F. Smith earned more than 83.3% of executives in this industry.

Non-Equity Incentive Plan$391,500
Option Awards$1,231,888
Salary$444,234
Stock Awards$182,900
Other$11,804
Total$2,262,326

Smith received $1,231,888 in option awards, which accounts for 54.45% of total compensation.

Smith also received $391,500 in non-equity incentive plan, $444,234 in salary, $182,900 in stock awards and $11,804 in other compensation.

2007

In 2007, Ian F. Smith earned a total compensation of $3,372,273 as Executive Vice President and Chief Financial Officer at Vertex Pharmaceuticals.

Ranking1,151 out of 6,983
Percentile83.5%

Ian F. Smith's 2007 compensation ranked 1,151st out of 6,983 executive pay records tracked by us this year.

Ian F. Smith earned more than 83.5% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking39 out of 312
Percentile87.5%

In the industry of pharmaceutical preparations, Ian F. Smith's 2007 pay ranked 39th, among 312 executive pay records.

Ian F. Smith earned more than 87.5% of executives in this industry.

Non-Equity Incentive Plan$141,907
Option Awards$1,641,900
Salary$411,595
Stock Awards$1,164,328
Other$12,543
Total$3,372,273

Smith received $1,641,900 in option awards, which accounts for 48.69% of total compensation.

Smith also received $141,907 in non-equity incentive plan, $411,595 in salary, $1,164,328 in stock awards and $12,543 in other compensation.

2006

In 2006, Ian F. Smith earned a total compensation of $1,914,697 as Executive Vice President and Chief Financial Officer at Vertex Pharmaceuticals.

Ranking1,454 out of 5,364
Percentile72.9%

Ian F. Smith's 2006 compensation ranked 1,454th out of 5,364 executive pay records tracked by us this year.

Ian F. Smith earned more than 72.9% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking41 out of 296
Percentile86.1%

In the industry of pharmaceutical preparations, Ian F. Smith's 2006 pay ranked 41st, among 296 executive pay records.

Ian F. Smith earned more than 86.1% of executives in this industry.

Non-Equity Incentive Plan$313,995
Option Awards$983,692
Salary$395,830
Stock Awards$209,889
Other$11,291
Total$1,914,697

Smith received $983,692 in option awards, which accounts for 51.38% of total compensation.

Smith also received $313,995 in non-equity incentive plan, $395,830 in salary, $209,889 in stock awards and $11,291 in other compensation.